Earnings History Data for Exagen Inc. (XGN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Exagen Inc.
Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-03-2025 | PM | XGN | Exagen Inc. | 56.97 | -0.20 | -0.27 | -0.31 | Exagen GAAP EPS of -$0.20 beats by $0.03, revenue of $13.66M misses by $0.19M [3/11/2025 8:04 AM] |
3.33 | 0.48 (16.85%) |
3.00 | 0.15 (5.27%) |
1.31 - 6.22 | 142,172 | 90,000 | 1,015 | ||
| 12-11-2024 | PM | XGN | Exagen Inc. | 49.55 | -0.28 | -0.30 | -0.31 | Exagen GAAP EPS of -$0.28, revenue of $12.5M [11/12/2024 9:39 AM] |
2.75 | -0.23 (-7.58%) |
3.00 | 0.03 (1.01%) |
1.30 - 3.71 | 42,548 | 20,000 | 1,055 | ||
| 05-08-2024 | PM | XGN | Exagen Inc. | 34.92 | -0.16 | -0.36 | -0.28 | Exagen GAAP EPS of $0.16 beats by $0.50, revenue of $15.1M beats by $1.97M [8/5/2024 9:34 AM] |
2.35 | 0.31 (15.44%) |
2.12 | 0.08 (3.92%) |
1.30 - 2.95 | 398,818 | 30,000 | 4,642 | ||
| 13-05-2024 | PM | XGN | Exagen Inc. | 24.30 | -0.19 | -0.40 | -0.44 | Exagen beats top-line and bottom-line estimates; raises FY24 outlook [5/13/2024 8:03 AM] |
1.60 | 0.03 (1.91%) |
1.69 | 0.12 (7.64%) |
1.30 - 3.92 | 166,697 | 20,000 | 16,143 | ||
| 18-03-2024 | PM | XGN | Exagen Inc. | 29.32 | -0.31 | -0.41 | -0.58 | Exagen reports Q4 results [3/18/2024 11:27 AM] |
1.83 | 0.21 (12.96%) |
1.98 | 0.36 (22.22%) |
1.33 - 3.92 | 179,522 | 30,000 | 12,180 | ||
| 13-11-2023 | AH | XGN | Exagen Inc. | 25.29 | -0.31 | -0.50 | -0.47 | Exagen GAAP EPS of -$0.31 beats by $0.15, revenue of $13.4M beats by $3.07M [11/13/2023 4:28 PM] |
1.71 | 0.25 (17.12%) |
1.59 | 0.13 (8.90%) |
1.33 - 4.20 | 68,529 | 10,000 | 513 | ||
| 07-08-2023 | PM | XGN | Exagen Inc. | 41.39 | -0.28 | -0.47 | -0.78 | Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook [8/7/2023 8:09 AM] |
2.80 | 0.29 (11.55%) |
2.84 | 0.33 (13.15%) |
2.04 - 6.50 | 93,571 | 10,000 | 1,333 | ||
| 15-05-2023 | AH | 4:05 PM ET (May 15) |
XGN | Exagen Inc. | 48.79 | -0.44 | -0.52 | -0.60 | Exagen GAAP EPS of -$0.44 beats by $0.12, revenue of $11.2M beats by $1.8M [5/15/2023 4:09 PM] |
3.63 | 0.72 (24.66%) |
0.0 | 0.0 (0.00%) |
2.04 - 8.96 | 204,866 | 10,000 | 0 | |
| 20-03-2023 | AH | 4:05 PM ET (Mar 20) |
XGN | Exagen Inc. | 45.04 | -0.58 | -0.71 | -0.42 | Exagen GAAP EPS of -$0.83 misses by $0.07, revenue of $12.84M beats by $4.14M [3/20/2023 4:10 PM] |
2.25 | -0.10 (-4.26%) |
2.00 | -0.35 (-14.89%) |
2.04 - 9.44 | 62,500 | 20,000 | 12,219 | |
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
XGN | Exagen Inc. | 35.61 | -0.47 | -0.76 | -0.42 | Exagen GAAP EPS, revenue beats, FY22 guidance raised [11/14/2022 4:08 PM] |
2.82 | 0.72 (34.29%) |
0.0 | 0.0 (0.00%) |
2.10 - 14.01 | 202,535 | 70,000 | 0 | |
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
XGN | Exagen Inc. | 130.37 | -0.78 | -0.55 | -0.38 | Exagen GAAP EPS of -$0.78 misses by $0.21, revenue of $8.96M misses by $3.07M [8/4/2022 5:03 PM] |
6.34 | -1.96 (-23.61%) |
3.92 | -0.40 (-9.26%) |
4.15 - 14.90 | 73,886 | 20,000 | 51,552 | |
| 11-05-2022 | AH | 4:05 PM ET (May 11) |
XGN | Exagen Inc. | 96.72 | -0.60 | -0.59 | -0.48 | Exagen GAAP EPS of -$0.60 beats by $0.01, revenue of $10.4M beats by $0.4M [5/11/2022 4:10 PM] |
5.24 | -0.26 (-4.73%) |
6.56 | 0.0 (0.00%) |
5.01 - 17.58 | 60,841 | 70,000 | 870 | |
|
||||||||||||||||||
| 22-03-2022 | AH | 4:05 PM ET (Mar 22) |
XGN | Exagen Inc. | 143.22 | -0.42 | -0.49 | -0.27 | Exagen GAAP EPS of -$0.42 beats by $0.04, revenue of $12.69M beats by $0.97M [3/22/2022 4:22 PM] |
8.90 | 0.52 (6.21%) |
8.79 | 0.41 (4.89%) |
6.84 - 18.86 | 87,032 | 30,491 | 309 | |
|
||||||||||||||||||
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
XGN | Exagen Inc. | 203.84 | -0.42 | -0.43 | -0.34 | Exagen EPS beats by $0.02, beats on revenue [11/10/2021 4:22 PM] |
14.36 | 1.16 (8.79%) |
13.20 | 0.0 (0.00%) |
10.12 - 24.67 | 34,914 | 40,000 | 709 | |
| 09-08-2021 | AH | 4:05 PM ET (Aug 9) |
XGN | Exagen Inc. | 201.79 | -0.38 | -0.50 | -0.27 | Exagen EPS beats by $0.05, beats on revenue [8/9/2021 4:57 PM] |
12.55 | 2.30 (22.44%) |
0.0 | 0.0 (0.00%) |
10.12 - 24.67 | 643,350 | 40,000 | 0 | |
|
||||||||||||||||||
| 11-05-2021 | AH | 4:05 PM ET (May 11) |
XGN | Exagen Inc. | 259.47 | -0.48 | -0.46 | -0.44 | Exagen EPS misses by $0.03, beats on revenue [5/11/2021 4:29 PM] |
12.77 | -2.29 (-15.21%) |
0.0 | 0.0 (0.00%) |
10.29 - 24.67 | 116,502 | 50,000 | 0 | |
| 16-03-2021 | AH | 4:05 PM ET (Mar 16) |
XGN | Exagen Inc. | 253.30 | -0.27 | -0.33 | -0.27 | Exagen EPS beats by $0.11, beats on revenue [3/16/2021 4:29 PM] |
21.91 | 1.61 (7.93%) |
21.00 | 0.51 (2.49%) |
10.29 - 24.67 | 13,543 | 50,173 | 1,000 | |
|
||||||||||||||||||
| 10-11-2020 | AH | 4:05 PM ET (Nov 10) |
XGN | Exagen Inc. | 199.21 | -0.34 | -0.48 | -11.29 | Exagen EPS beats by $0.14, beats on revenue [11/10/2020 4:37 PM] |
15.70 | -0.35 (-2.18%) |
16.04 | -0.01 (-0.04%) |
10.29 - 29.86 | 4,313 | 10,221 | 3,133 | |
|
|
||||||||||||||||||